-
1.发明公开VACCINE FOR HPV INFECTION AND/OR HEPATITIS B CONTAINING HPV/HBS CHIMERIC PROTEIN AS ACTIVE INGREDIENT 审中-公开疫苗HPV感染和/或乙型肝炎嵌合HPV / HBS-蛋白ACTIVE
公开(公告)号：EP2940133A4
公开(公告)日：2016-07-06
申请号：EP13868570
申请日：2013-11-28
IPC分类号： C12N15/09 , A61K39/00 , A61K39/12 , A61K39/29 , A61K48/00 , A61P31/20 , A61P35/00 , C07K14/02 , C07K14/025 , C07K19/00 , C12N1/15 , C12N1/19 , C12N1/21 , C12N5/10
CPC分类号： C07K14/005 , A61K39/12 , A61K2039/70 , C07K2319/00 , C12N2710/20034 , C12N2730/10134
-
公开(公告)号：EP0774513A4
公开(公告)日：1999-10-13
申请号：EP96914457
申请日：1996-05-28
IPC分类号： G01N33/53 , A61K39/00 , A61K39/255 , A61P31/12 , C07H21/04 , C07K14/03 , C07K14/125 , C07K16/00 , C12N7/00 , C12N7/01 , C12N15/09 , C12N15/38 , C12N15/869 , C12R1/92 , G01N33/569 , A61K39/245 , C12N15/86
CPC分类号： C12N15/86 , A61K2039/53 , C07K14/005 , C12N2710/16343 , C12N2760/18122 , Y10S424/816
摘要： A recombinant Herpesvirus capable of effectively expressing the target alien protein in a host animal which has been inoculated therewith and exerting an excellent immunological effect. The recombinant Herpesvirus has an alien gene expression cassette integrated thereinto wherein a gB gene originating in Herpesvirus (a gene homologous with Herpes simplex virus gB gene) promoter is employed as a promoter for the expression of the alien gene.
-
3.发明公开PROCESS FOR PRODUCING ERYSIPELOTHRIX RHUSIOPATHIAE SURFACE PROTECTIVE ANTIGEN MUTANT IN ESCHERICHIA COLI 有权一种用于生产猪红斑丹毒丝OBERFLÄCHENPROTEKTIVEN抗原突变体大肠杆菌
公开(公告)号：EP1724342A4
公开(公告)日：2008-08-13
申请号：EP05709866
申请日：2005-02-08
CPC分类号： C07K14/195 , A61K38/00 , A61K39/00
摘要： It is intended to provide a mutant of a surface protective antigen SpaA protein of Erysipelothrix rhusiopathiae or a shortened SpaA protein (DeltaSpaA) obtained by removing a part therefrom and a process for producing the same. By introducing an amino acid substituent into a definite position of the amino acid sequence of the SpaA protein or the DeltaSpaA protein, a mutant of the SpaA protein or the DeltaSpaA protein having immunogenicity and being expressed as an inclusion body in Escherichia coli can be obtained. Because of being expressed as an insoluble inclusion body in Escherichia coli, the above-described mutant of the SpaA protein or the DeltaSpaA protein can be easily collected and purified.
-
公开(公告)号：EP2829281A4
公开(公告)日：2015-11-11
申请号：EP13763687
申请日：2013-02-19
IPC分类号： A61K39/02 , A61K39/102 , A61K39/108 , A61K39/112 , A61K39/12 , A61K39/17 , A61P31/00
CPC分类号： A61K39/0275 , A61K39/0208 , A61K39/0241 , A61K39/025 , A61K39/04 , A61K39/102 , A61K39/17 , A61K39/215 , A61K39/235 , A61K39/295 , A61K2039/552 , A61K2039/6037 , A61K2039/70 , C12N7/00 , C12N2710/10234 , C12N2710/10271 , C12N2770/20034 , C12N2770/20071
摘要： A vaccine composition for birds comprising as an active ingredient a structure containing 0-antigen derived from Gram-negative bacteria, provided that said structure does not contain a whole cell, and a process for preparing the same are provided. By using a structure containing 0-antigen (e.g. lipopolysaccharide) derived from Gram-negative bacteria as an active ingredient in accordance with the present invention, alleviation of inoculation reaction and reduction in an amount of injection are attained as compared to the conventional whole -cells vaccine to thereby allow for the increase in the number of other antigens to be mixed therewith.
摘要翻译： 一种用于鸟类的疫苗组合物，其包含作为活性成分的含有衍生自革兰氏阴性细菌的O-抗原的结构，条件是所述结构不包含全细胞，并提供其制备方法。 通过使用根据本发明的由革兰氏阴性细菌衍生的O-抗原（例如脂多糖）作为活性成分的结构，与常规全细胞相比，获得了接种反应的减轻和注射量的减少 疫苗，从而允许增加与其混合的其它抗原的数量。
-
公开(公告)号：EP2382985A4
公开(公告)日：2013-05-29
申请号：EP09834924
申请日：2009-12-24
IPC分类号： A61K39/02 , A61K39/102 , A61P31/04 , A61P37/04
CPC分类号： A61K39/02 , A61K39/102 , C07K14/465
-
6.发明公开
公开(公告)号：EP2251693A4
公开(公告)日：2011-04-20
申请号：EP09709287
申请日：2009-02-06
IPC分类号： G01N33/569 , C07K14/195 , C07K16/12
CPC分类号： C07K16/1242 , C07K14/195 , C07K2317/23 , G01N33/56911 , G01N2469/20 , G01N2800/14
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.012 秒)
